EBV BZLF1 (40-48) (HLA-E)
Ref. 3D-CRB1001207
1mg
254.00€
500µg
186.00€
Product Information
Name:EBV BZLF1 (40-48) (HLA-E)
Synonyms:
- H-SQAPLPCVL-OH
Brand:Biosynth
Description:EBV BZLF1 (40-48) (HLA-E) is an immunodominant CEF control peptide that is derived from the Epstein-Barr virus (EBV). EBV targets B cells, which can cause lytic infection and the consequent death of these cells. Natural killer (NK) cells, invariant (iNKT) cells, CD4T cells and CD8 T cells are essential to control the action of EBV-infected cells. EBV BZLF1 (40-48) (HLA-E) is defined as a CEF control peptide due to its antigenic properties. Clinically, these peptides are suitable epitopes for CD8+ T cells and can be used to stimulate the release of IFNg. HLA-E refers to the cell HLA type that this peptide acts on.The BZLF1 protein mediates the transition from the latent stage to the lytic stage of the virus's infection. The lytic stage of the γ herpesvirus has been found to be associated with human carcinogenesis and BZLF1's ability to activate p53 may allow it to induce DNA damage. Structurally it is similar to the leucine zipper family of transcriptional factors.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:926.5 g/mol
Technical inquiry about: EBV BZLF1 (40-48) (HLA-E)
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.